Program
Program
Scientific Program
  • Program at a Glance
  • Scientific Program
  • Invited Faculty
  • Social Program
  • Search
  • Search initialized
  • Time Converter
Time zone is Korean Standard Time (GMT +9)

Full Program

May 16 (Thu), 2024

May 17 (Fri), 2024

May 18 (Sat), 2024

    Find programs by category
  • May 16(Thu)
  • 09:00-10:00
  •  
  • Presidential Plenary Session 
  • Room1
  • Korean-English
  • Chairs
  • Jae-Bum Jun (Hanyang Univ., Korea)
  • Shin-Seok Lee (Chonnam Nat'l Univ., Korea)
  • 09:00-09:30
  • 09:30-10:00
  • May 16(Thu)
  • 10:30-12:00
  •  
  • Year in Review, Clinical Science 
  • Room1
  • English
  • Chairs
  • Kichul Shin (Seoul Nat'l Univ., Korea)
  • Chan Hong Jeon (Soonchunhyang Univ., Korea)
  • 10:30-11:00
  • 11:00-11:30
  • 11:30-12:00
  • May 16(Thu)
  • 10:30-12:00
  •  
  • Year in Review, Basic Science 
  • Room2
  • English
  • Chairs
  • Yong-Wook Park (Chonnam Nat'l Univ., Korea)
  • Sang-il Lee (Gyeongsang Nat'l Univ., Korea)
  • 10:30-11:00
  • 11:00-11:30
  • 11:30-12:00
  • May 16(Thu)
  • 12:00-13:00
  • Luncheon Symposium 1 [Eisai]
  • A well-Balanced JAKi for Patients with RA 
  • Room1
  • English
  • Chair
  • Seungjae Hong (Kyung Hee Univ., Korea)
  • 12:00-13:00
  • May 16(Thu)
  • 12:00-13:00
  • Luncheon Symposium 2 [Celltrion]
  • From Biosimilar to Biobetter 
  • Room2
  • English
  • Chair
  • Jung Soo Song (Chung-ang Univ., Korea)
  • 12:00-13:00
  • Infliximab SC: A new therapeutic option in rheumatic disease
  • May 16(Thu)
  • 12:00-13:00
  • Luncheon Symposium 3 [Astellas]
  • Tacrolimus for Rheumatoid Arthritis 
  • Room3
  • English
  • Chair
  • Sung Hwan Park (The Catholic Univ. of Korea, Korea)
  • 12:00-13:00
  • Efficacy and safety of tacrolimus in the treatment of RA patients
  • May 16(Thu)
  • 13:00-14:30
  •  
  • International Symposium 1_Recent advances in Immunopathogenesis of SLE 
  • Room1
  • English
  • Chairs
  • Sang-Cheol Bae (Hanyang Univ., Korea)
  • Jisoo Lee (Ewha Womans Univ., Korea)
  • 13:00-13:30
  • 13:30-14:00
  • 14:00-14:30
  • May 16(Thu)
  • 13:00-14:30
  •  
  • KCR-KOA Joint Symposium_Surgical Management of RA 
  • Room2
  • English
  • Chairs
  • Jae-Bum Jun (Hanyang Univ., Korea)
  • Myung Chul Lee (SNU Seoul Hosp., Korea)
  • 13:00-13:30
  • 13:30-14:00
  • 14:00-14:30
  • May 16(Thu)
  • 13:00-13:50
  •  
  • Free Paper Session 1_Behcet's Disease & Vasculitis 
  • Room3
  • Engligh
  • Chairs
  • Chan-Bum Choi (Hanyang Univ., Korea)
  • Sang-Won Lee (Yonsei Univ., Korea)
  • 13:00-13:10
  • (KO-001) Impact of prophylactic trimethoprim-sulfamethoxazole on the incidence of serious infection in patients with ANCA-associated vasculitis: A multicenter cohort study
  • 13:10-13:20
  • (KO-002) Progression to ANCA-associated vasculitis in patients with idiopathic interstitial pneumonia and positive ANCA results
  • 13:20-13:30
  • (KO-003) Associative factors of pauci-immune glomerulonephritis in patients undergoing renal biopsy with positive ANCA results
  • May 16(Thu)
  • 13:50-14:30
  •  
  • Free Paper Session 2_Pediatric Rheumatology 
  • Room3
  • Engligh
  • Chairs
  • Ji Seon Oh (Asan Medical Center, Korea)
  • Jung-Woo Rhim (The Catholic Univ. of Korea, Korea)
  • 13:50-14:00
  • (KO-005) Population-based big data analysis on disease patterns in patients identified with Juvenile Idiopathic arthritis using national claims data
  • 14:00-14:10
  • 14:10-14:20
  • 14:20-14:30
  • May 16(Thu)
  • 15:30-16:30
  •  
  • International Joint Symposium (KCR and APLAR Member) 
  • Room1
  • English
  • Chairs
  • Shin-Seok Lee (Chonnam Nat'l Univ., Korea)
  • Tsutomu Takeuchi (Saitama Medical Univ., Japan)
  • 15:30-16:00
  • 16:00-16:30
  • Unmet needs in the pharmacological treatment of rheumatoid arthritis
  • May 16(Thu)
  • 15:30-16:30
  •  
  • Free Paper Session 3_Spondyloarthropathy I 
  • Room2
  • Engligh
  • Chairs
  • Hyun-Ok Kim (Gyeongsang Nat'l Univ., Korea)
  • Hoon-Suk Cha (Sungkyunkwan Univ., Korea)
  • 15:30-15:40
  • (KO-009) Flare prediction after tapering the dose of tumor necrosis factor inhibitors in patients with axial spondyloarthritis: A nationwide cohort study
  • Jina Yeo (Gachon Univ., Korea)
  • 15:40-15:50
  • (KO-010) Risk of spondyloarthritis in patients with inflammatory bowel disease under treatment with biologics or janus kinase inhibitors
  • 15:50-16:00
  • (KO-012) Performance of the 2021/2022 ASAS criteria for defining sacroiliitis/spondylitis in patients with psoriatic arthritis
  • 16:00-16:10
  • (KO-084) Dosage reduction of tumor necrosis factor inhibitors may have a negative effect on slowing early radiographic progression in patients with ankylosing spondylitis
  • 16:10-16:20
  • 16:20-16:30
  • (KO-011) Artificial intelligence to predict disease activity using a multimodal model with magnetic resonance imaging and laboratory results in patients with axial spondyloarthritis
  • May 16(Thu)
  • 15:30-16:30
  •  
  • Free Paper Session 4_Basic Research I 
  • Room3
  • Engligh
  • Chairs
  • Young Mo Kang (Kyungpook Nat'l Univ., Korea)
  • Jungsik Song (Yonsei Univ., Korea)
  • 15:30-15:40
  • (KO-013) Integration of single-cell multi-omics profiling for investigating treatment response to tumor necrosis factor alpha inhibitors in patients with axial spondyloarthritis
  • 15:40-15:50
  • 15:50-16:00
  • 16:00-16:10
  • 16:10-16:20
  • (KO-016) Potential of exosome-derived miRNA as a biomarker in adult-onset still's disease
  • May 16(Thu)
  • 16:30-17:30
  •  
  • International Joint Symposium (KCR and APLAR Member) 
  • Room1
  • English
  • Chairs
  • Sang-Heon Lee (Konkuk Univ., Korea)
  • Kichul Shin (Seoul Nat'l Univ., Korea)
  • 16:30-17:00
  • 17:00-17:30
  • May 16(Thu)
  • 16:30-17:30
  •  
  • Free Paper Session 5_Crystal Induced Arthropathies 
  • Room2
  • Engligh
  • Chairs
  • Jung Soo Song (Chung-Ang Univ., Korea)
  • Ki Won Moon (Kangwon Nat'l Univ., Korea)
  • 16:30-16:40
  • 16:40-16:50
  • (KO-018) Long-term cardiovascular risk according to genetic risk for gout, lifestyle, and metabolic health: Discovery and replication analysis of two diverse prospective cohorts
  • 16:50-17:00
  • (KO-019) Risk of gout among patients with tuberculosis: A nationwide cohort study in South Korea
  • May 16(Thu)
  • 16:30-17:30
  •  
  • Free Paper Session 6_Basic Research II 
  • Room3
  • Engligh
  • Chairs
  • Wan-Uk Kim (The Catholic Univ. of Korea, Korea)
  • Eon Jeong Nam (Kyungpook Nat'l Univ., Korea)
  • 16:30-16:40
  • (KO-020) Rebamipide attenuates renal manifestations via antioxidant effects on podocytes in an animal model for systemic lupus erythematosus
  • 16:40-16:50
  • (KO-021) Linc01150 promotes lymphatic infiltration in primary sjogren's syndrome by binding MiR-1207-5p to express IL-10
  • 16:50-17:00
  • 17:00-17:10
  • 17:10-17:20
  • 17:20-17:30
  • (KO-090) Osteoarthritis drives inflammatory imprinting of dynovial fibroblasts, exacerbating gouty arthritis through m6A modification modification of S100A4
  • May 16(Thu)
  • 17:45-18:30
  • Evening Symposium 1 [JW]
  • Drug Retention and Safety of Rheumatoid Arthritis Treatment 
  • Room2
  • English
  • Chair
  • Wan-Uk Kim (The Catholic Univ. of Korea, Korea)
  • 17:30-18:30
  • May 16(Thu)
  • 17:45-18:30
  • Evening Symposium 2 [Lilly]
  • Advances in Axial Spondyloarthritis 
  • Room3
  • English
  • Chair
  • Eun Young Lee (Seoul Nat'l Univ., Korea)
  • 17:30-18:30
  • May 17(Fri)
  • 08:00-09:00
  • Breakfast Symposium 1 [Abbvie]
  • Unleash the Vast Potential of JAK Inhibitors for Patients with Axial Spondyloarthritis 
  • Room1
  • English
  • Chair
  • Min-Chan Park (Yonsei Univ., Korea)
  • 08:00-09:00
  • Optimizing patient care in Axial Spondyloarthritis
  • May 17(Fri)
  • 08:00-09:00
  • Breakfast Symposium 2 [Eisai]
  • A Well-Balanced JAKi for Patients with RA 
  • Room2
  • English
  • Chair
  • Sang Hyon Kim (Keimyung Univ., Korea)
  • 08:00-09:00
  • May 17(Fri)
  • 08:00-09:00
  • Breakfast Symposium 3 [Novartis]
  • In-Depth Review of Treatment Options in AS 
  • Room3
  • English
  • Chair
  • Sang-Heon Lee (Konkuk Univ., Korea)
  • 08:00-09:00
  • What distinguishes Secukinumab as an optimal choice in AS?
  • May 17(Fri)
  • 09:00-10:00
  •  
  • Keynote Lecture 1 
  • Room1
  • English-Korean
  • Chair
  • Shin-Seok Lee (Chonnam Nat'l Univ., Korea)
  • 09:00-10:00
  • May 17(Fri)
  • 10:30-12:00
  •  
  • International Symposium 2_Optimal Care for Patients with Rheumatic Diseases: Minimizing Treatment-Related Infectious Complications 
  • Room1
  • English
  • Chairs
  • Bin Yoo (Univ. of Ulsan, Korea)
  • Eun Bong Lee (Seoul Nat'l Univ., Korea)
  • 10:30-11:00
  • 11:00-11:30
  • 11:30-12:00
  • May 17(Fri)
  • 10:30-11:20
  •  
  • Free Paper Session 7_Rheumatoid Arthritis Clinical Research I 
  • Room2
  • Engligh
  • Chairs
  • WonTae Chung (Dong-A Univ., Korea)
  • Gwan Gyu Song (Korea Univ., Korea)
  • 10:30-10:40
  • 10:40-10:50
  • (KO-025) Validation of boolean 2.0 criteria for assessing remission and predicting quality of life in Korean patients with rheumatoid arthritis undergoing targeted therapy
  • 10:50-11:00
  • 11:00-11:10
  • (KO-027) Exploring risk factors for adverse events and infections in RA and RA with ILD under treatment with biologics or targeted synthetic DMARDs: Findings from the KOBIO registry
  • 11:10-11:20
  • (KO-028) Comprehensive analysis of patients with rheumatoid arthritis with interstitial lung disease: Clinical characteristics, treatment patterns, and prognostic factors
  • May 17(Fri)
  • 10:30-11:20
  •  
  • Free Paper Session 8_Osteoarthritis & Orthopedics 
  • Room3
  • Engligh
  • Chairs
  • Gunil Im (Dongguk Univ., Korea)
  • Hyun Sik Gong (Seoul Nat'l Univ., Korea)
  • 10:30-10:40
  • (KO-029) Association between metabolic marker and knee osteoarthritis: A cross-sectional study using the Korea National Health And Nutrition Examination Survey 2009 to 2013
  • Junyong Park (Dong-A Univ. Hosp., Korea)
  • 10:40-10:50
  • 10:50-11:00
  • 11:00-11:10
  • May 17(Fri)
  • 11:20-12:00
  •  
  • Free Paper Session 9 (11:20 - 12:00) Rheumatoid Arthritis Clinical Research II 
  • Room2
  • Engligh
  • Chairs
  • Jinseok Kim (Jeju nat'l Univ., Korea)
  • Seonghoon Park (Catholic Univ. of Daegu, Korea)
  • 11:20-11:30
  • 11:30-11:40
  • (KO-035) Effects of cumulative lifetime estrogen exposure on the clinical characteristics and courses in postmenopausal women with rheumatoid arthritis
  • 11:40-11:50
  • (KO-036) Early-life environmental influences on rheumatoid arthritis risk: Insights from a large retrospective study in Chinese adults
  • 11:50-12:00
  • (KO-037) Impact of glucocorticoids on the therapeutic efficacy of denosumab in osteoporosis of rheumatoid arthritis patients
  • May 17(Fri)
  • 11:20-12:00
  •  
  • Free Paper Session 10_Experimental Osteoarthritis 
  • Room3
  • Engligh
  • Chairs
  • Sung Won Lee (Dong-A Univ., Korea)
  • Seungwoo Han (Kyungpook Nati'l Univ., Korea)
  • 11:20-11:30
  • (KO-038) GelMA hydrogel microspheres integrating fullerenol and extracellular vesicles alleviate osteoarthritis
  • 11:30-11:40
  • 11:40-11:50
  • 11:50-12:00
  • (KO-041) Therapeutic efficacy and safety of intra articular injection of human bone marrow derived mesenchymal stem cells in knee osteoarthritis; randomized, double-blind, placebo-controlled clinical trial
  • Bong-Woo Lee (The Catholic Univ. of Korea, Korea)
  • May 17(Fri)
  • 12:00-13:00
  • Luncheon Symposium 4 [Samsung Bioepis]
  • TNF Inhibition 
  • Room1
  • English
  • Chair
  • Jung-Yoon Choe (Daegu Catholic Univ., Korea)
  • 12:00-13:00
  • What we have learned and what we need find out from TNF inhibition for chronic inflammatory arthritis
  • May 17(Fri)
  • 12:00-13:00
  • Luncheon Symposium 5 [Amgen]
  • AMGEN_Osteoporosis Treatment in Rheumatology Patients 
  • Room2
  • English
  • Chair
  • Chang-Hee Suh (Ajou Univ., Korea)
  • 12:00-13:00
  • Treatment journey to protect bone fractures
  • May 17(Fri)
  • 12:00-13:00
  • Luncheon Symposium 6 [Janssen]
  • Patient-Specific Care in Rheumatic Diseases 
  • Room3
  • English
  • Chair
  • Seung Cheol Shim (Chungnam Nat'l Univ., Korea)
  • 12:00-13:00
  • May 17(Fri)
  • 13:00-14:30
  •  
  • International Symposium 3_Application of Digital Technology in Health Care for Patients with Rheumatic Diseases 
  • Room1
  • English
  • Chairs
  • Jung-Yoon Choe (Daegu Catholic Univ., Korea)
  • Hyun Ah Kim (Hallym Univ., Korea)
  • 13:00-13:30
  • 13:30-14:00
  • 14:00-14:30
  • May 17(Fri)
  • 13:00-14:30
  •  
  • KCR-KSBMR Joint Symposium_Anabolic Treatment for Osteoporosis 
  • Room2
  • English
  • Chairs
  • Shin-Seok Lee (Chonnam Nat'l Univ., Korea)
  • Ki Hyun Baek (The Catholic Univ. of Korea, Korea)
  • 13:00-13:30
  • 13:30-14:00
  • 14:00-14:30
  • May 17(Fri)
  • 13:00-13:50
  •  
  • Free Paper Session 11_Sjögren's Syndrome & Inflammatory Myopathy 
  • Room3
  • Engligh
  • Chairs
  • Yun Jong Lee (Seoul Nat'l Univ., Korea)
  • Yeon-Ah Lee (Kyung Hee Univ., Korea)
  • 13:00-13:10
  • 13:10-13:20
  • 13:20-13:30
  • (KO-044) Clinical value of salivary gland ultrasonography in evaluating secretory function, disease activity and lymphoma risk factors in primary Sjögren's syndrome
  • 13:30-13:40
  • 13:40-13:50
  • May 17(Fri)
  • 13:50-14:30
  •  
  • Free Paper Session 12_Systemic Sclerosis 
  • Room3
  • Engligh
  • Chair
  • Jin Kyun Park (Seoul Nat'l Univ., Korea)
  • 13:50-14:00
  • (KO-046) The risk of stroke and myocardial infarction in systemic sclerosis: A population-based study
  • 14:00-14:10
  • 14:10-14:20
  • (KO-048) Association of vitamin D levels in systemic sclerosis patients: A meta-analysis
  • May 17(Fri)
  • 15:30-16:30
  •  
  • Free Paper Session 13_Systemic Lupus Erythematosus & Antiphospholipid Syndrome 
  • Room1
  • Engligh
  • Chairs
  • Sung Hwan Park (The Catholic Univ. of Korea, Korea)
  • Yong-Beom Park (Yonsei Univ., Korea)
  • 15:30-15:40
  • (KO-049) Clinical relevance of the systemic lupus erythematosus disease activity score (SLE-DAS) in predicting lupus outcomes: A 5-year longitudinal cohort study
  • 15:40-15:50
  • (KO-050) Monitoring disease activity and treatment response in Korean patients with systemic lupus erythematosus: A longitudinal study of urinary ALCAM, hemopexin, and PRDX6
  • 15:50-16:00
  • 16:00-16:10
  • (KO-052) Antiphospholipid syndrome in pediatric lupus- clinico- laboratory manifestation and long term follow up - a 25 years experience from Northwest India
  • Abarna Thangaraj (PGIMER, India)
  • 16:10-16:20
  • (KO-053) Hyperuricemia as a prognostic marker for antiphospholipid syndrome: A cohort study of Chinese patients
  • May 17(Fri)
  • 15:30-16:30
  •  
  • Medical Humanities Session 
  • Room2
  • Korean
  • Chairs
  • Young Ho Lee (Korea Univ., Korea)
  • Sang Hyon Kim (Keimyung Univ., Korea)
  • 15:30-16:30
  • 16:30-17:30
  • May 17(Fri)
  • 15:30-16:30
  •  
  • Free Paper Session 14_Fibromyalgia and Soft Tissue Disorders 
  • Room3
  • Engligh
  • Chairs
  • Tae-Jong Kim (Chonnam Nat'l Univ., Korea)
  • Jinhyun Kim (Chungnam Nat'l Univ., Korea)
  • 15:30-15:40
  • (KO-054) Mind-body interventions in the management of fibromyalgia: Effects on pain perception, psychological well-being, and quality of life
  • 15:40-15:50
  • (KO-055) Study of quality of life, metabolic and oxidative stress biomarkers in fibromyalgia patients
  • 15:50-16:00
  • (KO-056) Exploring arthritis risk factors and their association with metabolic syndrome in Indonesia: Insights from the Indonesia family life study
  • 16:00-16:10
  • (KO-057) To characterise cases of de novo check point inhibitor (CPI) induced polyarthritis in cancer patients treated at a tertiary referral centre
  • Jang Yoon (Westmead Hosp., Australia)
  • 16:10-16:20
  • May 17(Fri)
  • 16:30-17:30
  •  
  • Free Paper Session 15_Lupus Nephritis 
  • Room1
  • Engligh
  • Chairs
  • Seung Cheol Shim (Chungnam Nat'l Univ., Korea)
  • Hye-Soon Lee (Hanyang Univ., Korea)
  • 16:30-16:40
  • (KO-058) Predictors of renal function preservation in non-responders to induction therapy for proliferative lupus nephritis
  • 16:40-16:50
  • (KO-059) Lupus flare and recurrent lupus nephritis following kidney transplantation in patients with lupus nephritis
  • 16:50-17:00
  • 17:00-17:10
  • May 17(Fri)
  • 16:30-17:30
  •  
  • Free Paper Session 16_Basic Research III 
  • Room3
  • Engligh
  • Chairs
  • Yong-Gil Kim (Univ. of Ulsan, Korea)
  • Myeungsu Lee (Wonkwang Univ., Korea)
  • 16:30-16:40
  • (KO-062) Human nasal turbinate-derived stem cells with specific gene signatures (HAS2, CXCL1, KRTAP1-5, GSTT2B, and C4B) attenuate rheumatoid arthritis
  • 16:40-16:50
  • 16:50-17:00
  • (KO-064) Cyr61 activates mitochondrial autophagy and regulated the phenotype transformation of rheumatoid arthritis fibroblast-like synoviocytes via the ROS/Hif-1α/BNIP3 pathway
  • Yanni Gui (Peking Univ., China)
  • 17:00-17:10
  • (KO-065) Differential gender effect on rheumatoid arthritis-associated interstitial lung disease and potential steroid hormone mechanisms in SKG mice
  • 17:10-17:20
  • (KO-095) Swimming exercise improves muscle strength and modulates irisin expression to alleviates joint and gut inflammation in curdlan-injected SKG mice
  • Sungsin Jo (Soonchunhyang Univ., Korea)
  • 17:20-17:30
  • (KO-096) A genome wide association study on ankylosing spondylitis in Koreans identified new susceptibility loci
  • May 18(Sat)
  • 08:00-09:00
  • Breakfast Symposium 4 [Janssen]
  • Value of Golimumab as a TNF Inhibitor 
  • Room1
  • English
  • Chair
  • Jinseok Kim (Jeju nat'l Univ., Korea)
  • 08:00-09:00
  • May 18(Sat)
  • 08:00-09:00
  • Breakfast Symposium 5 [Pfizer]
  • Finding the Balance: Efficacious Treatment of AS While Managing Safety and Risk 
  • Room2
  • English
  • Chair
  • Tae-Hwan Kim (Hanyang Univ., Korea)
  • 08:00-09:00
  • Advanced treatment options for AS: How to choose?
  • May 18(Sat)
  • 08:00-09:00
  • Breakfast Symposium 6 [Samsung Bioepis]
  • Anti-TNF-α Treatment 
  • Room3
  • English
  • Chair
  • Seong-Ho Kim (Inje Univ., Korea)
  • 08:00-09:00
  • May 18(Sat)
  • 09:00-10:00
  •  
  • Keynote Lecture 2 
  • Room1
  • Korean-English
  • Chair
  • Jae-Bum Jun (Hanyang Univ., Korea)
  • 09:00-10:00
  • May 18(Sat)
  • 10:30-12:00
  •  
  • International Symposium 4_New Insights in Early Axial Spondyloarthritis 
  • Room1
  • English
  • Chairs
  • Tae-Hwan Kim (Hanyang Univ., Korea)
  • SEONG R. Kwon (Inha Univ., Korea)
  • 10:30-11:00
  • 11:00-11:30
  • 11:30-12:00
  • Discussion
  • May 18(Sat)
  • 10:30-11:20
  •  
  • Free Paper Session 17_Rheumatoid Arthritis : Treatment 
  • Room2
  • Engligh
  • Chairs
  • Chang Keun Lee (Ulsan Univ., Korea)
  • Chong-hyeon Yoon (The Catholic Univ. of Korea, Korea)
  • 10:30-10:40
  • (KO-066) Comparative effectiveness of subcutaneous sarilumab, subcutaneous tocilizumab, and intravenous tocilizumab in patients with rheumatoid arthritis: The answer cohort study
  • Akira Onishi (Kyoto Univ., Japan)
  • 10:40-10:50
  • (KO-067) Real-world comparative effectiveness study of janus kinase inhibitors compared to biologic disease modifying antirheumatic drugs in Korean patients with rheumatoid arthritis
  • 10:50-11:00
  • (KO-068) Effectiveness of tumor necrosis factor Inhibitors in combination with MTX or non-MTX csDMARDs in patients with rheumatoid arthritis: Data from the KOBIO registry
  • 11:00-11:10
  • (KO-069) Influence of fat mass and sarcopenia on treatment response of targeted therapy in rheumatoid arthritis: A single-center prospective study
  • 11:10-11:20
  • May 18(Sat)
  • 10:30-11:20
  •  
  • Free Paper Session 18 (10:30 -11:20) Epidemiology & Public Health I 
  • Room3
  • Engligh
  • Chairs
  • Geun Tae Kim (Kosin Univ., Korea)
  • Ki-Jo Kim (The Catholic Univ. of Korea, Korea)
  • 10:30-10:40
  • (KO-070) Association of rheumatoid arthritis with age-related macular degeneration: A nationwide cohort study
  • 10:40-10:50
  • (KO-071) The status of baseline screening ophthalmologic examinations in patients with rheumatic diseases starting hydroxychloroquine using health insurance review and assessment service database
  • 10:50-11:00
  • 11:00-11:10
  • (KO-073) Infertility and the chance of successful assisted assisted reproductive therapy in childbearing women with rheumatic diseases
  • 11:10-11:20
  • May 18(Sat)
  • 11:20-12:00
  •  
  • Free Paper Session 19 (11:20 - 12:00) Cancer in Rheumatic Disease 
  • Room2
  • Engligh
  • Chairs
  • Jaejoon Lee (Sungkyunkwan Univ., Korea)
  • Bo Young YOON (Inje Univ., Korea)
  • 11:20-11:30
  • (KO-074) Increased risk of cancer in patients with systemic sclerosis: A population-based study
  • 11:30-11:40
  • 11:40-11:50
  • (KO-076) Risk of gynecologic cancer among Korean women of childbearing age with rheumatic diseases
  • 11:50-12:00
  • (KO-077) Long-term cancer risk of tumor necrosis factor inhibitors in ankylosing spondylitis: A single-center cohort study
  • May 18(Sat)
  • 11:20-12:00
  •  
  • Free Paper Session 20_Epidemiology & Public Health II 
  • Room3
  • Engligh
  • Chair
  • Jinwuk Hur (Eulji Univ., Korea)
  • 11:20-11:30
  • (KO-078) A novel scoring system to predict serious infections in patients with rheumatic diseases receiving prolonged, high-dose glucocorticoid treatment
  • 11:30-11:40
  • (KO-079) Incidence of systemic vasculitides after mycobacterium tuberculosis infection: A population-based cohort study in Korea
  • 11:40-11:50
  • (KO-080) Human papillomavirus vaccination awareness in Chinese autoimmune inflammatory rheumatic diseases: A large real-world survey
  • Juan Zhao (Peking Univ., China)
  • May 18(Sat)
  • 12:00-13:00
  • Luncheon Symposium 7 [Novartis]
  • Paradigm Shift into New Mode of Action in AS Treatment 
  • Room1
  • English
  • Chair
  • Hoon-Suk Cha (Sungkyunkwan Univ., Korea)
  • 12:00-13:00
  • May 18(Sat)
  • 12:00-13:00
  • Luncheon Symposium 8 [GSK]
  • Evolving Rheumatology Care : A Deep Dive into Shingles Prevention for Rheumatic Patients 
  • Room2
  • English
  • Chair
  • Gwan Gyu Song (Korea Univ., Korea)
  • 12:00-13:00
  • Putting the patient first: The value of SHINGRIX for rheumatologic patient
  • May 18(Sat)
  • 12:00-13:00
  • Luncheon Symposium 9 [Abbvie]
  • Unleash the Vast Potential of JAK Inhibitors for Patients with Rheumatoid Arthritis 
  • Room3
  • English
  • Chair
  • Kichul Shin (Seoul Nat'l Univ., Korea)
  • 12:00-13:00
  • What remission means to patients versus to HCPs: Closing the gap with RINVOQ
  • May 18(Sat)
  • 13:00-14:30
  •  
  • International Symposium 5_Innovative Treatment in Autoimmune Rheumatic Diseases 
  • Room1
  • English
  • Chairs
  • Gunwoo Kim (Daegu Fatima Hosp., Korea)
  • Chang-Hee Suh (Ajou Univ., Korea)
  • 13:00-13:30
  • 13:30-14:00
  • 14:00-14:30
  • Discussion
  • May 18(Sat)
  • 13:00-14:30
  •  
  • KCR-KCPCI Joint Symposium_Current Status and Advances of Major Pediatric Rheumatic Diseases 
  • Room2
  • English
  • Chairs
  • Jae-Bum Jun (Hanyang Univ., Korea)
  • Dae-Chul Jeong (The Catholic Univ. of Korea, Korea)
  • 13:00-13:30
  • 13:30-14:00
  • 14:00-14:30
  • May 18(Sat)
  • 13:00-13:30
  •  
  • Free Paper Session 21_Spondyloarthritis II 
  • Room3
  • Engligh
  • Chair
  • Ji Hyeon Ju (The Catholic Univ. of Korea, Korea)
  • 13:00-13:10
  • (KO-081) Utility of a multi-biomarkers panel on predicting disease activity in patients with psoriatic arthritis – a derivation and validation study
  • 13:10-13:20
  • (KO-082) Using RNA-Seq data of TgA86 mouse model of spondyloarthritis
  • 13:20-13:30
  • (KO-083) Aortic inflammation and Wnt signaling undergo activation in the context of spondyloarthritis in the HLA-B27 transgenic rat model
  • May 18(Sat)
  • 13:30-14:30
  •  
  • Essential Healthcare Services in Korea: The Role of Rheumatology 
  • Room3
  • Korean
  • Chairs
  • Shin-Seok Lee (Chonnam Nat'l Univ., Korea)
  • Chong-hyeon Yoon (The Catholic Univ. of Korea, Korea)
  • 13:30-13:50
  • Rethinking essential healthcare service in Korea
  • 13:50-14:10
  • Consumer-centered rheumatologist education program